Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
Joe Yeong, Jeffrey Chun Tatt Lim, Bernett Lee, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy
Wei Tan, Sanjna Nilesh Nerurkar, Hai Yun Cai, et al.
Cancer Communications (2020) Vol. 40, Iss. 4, pp. 135-153
Open Access | Times Cited: 485
Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer
Yufan Qiu, Yi Yang, Ri‐Yao Yang, et al.
Oncogene (2021) Vol. 40, Iss. 31, pp. 4992-5001
Open Access | Times Cited: 103
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
Harry Ho Man Ng, Ren Yuan Lee, Siting Goh, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000987-e000987
Open Access | Times Cited: 100
Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma
Jason Yongsheng Chan, Jing Quan Lim, Joe Yeong, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 11, pp. 5833-5846
Open Access | Times Cited: 82
Prognostic value and immunological role of PDCD1 gene in pan-cancer
Yandong Miao, Jiangtao Wang, Qiutian Li, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107080-107080
Closed Access | Times Cited: 75
Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC
Joe Yeong, Lisda Suteja, Yannick Simoni, et al.
Journal of Thoracic Oncology (2021) Vol. 16, Iss. 8, pp. 1349-1358
Open Access | Times Cited: 69
Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID
Denise Goh, Jeffrey Chun Tatt Lim, Sonia Bilbao Fernaíndez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
Spatial immune scoring system predicts hepatocellular carcinoma recurrence
Gengjie Jia, Peiqi He, Tianli Dai, et al.
Nature (2025)
Closed Access | Times Cited: 1
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study
Parisa Lotfinejad, Mohammad Asghari Jafarabadi, Mahdi Abdoli Shadbad, et al.
Diagnostics (2020) Vol. 10, Iss. 9, pp. 704-704
Open Access | Times Cited: 69
Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC
Joe Yeong, Tira J. Tan, Zi Long Chow, et al.
Journal of Clinical Pathology (2020) Vol. 73, Iss. 9, pp. 557-562
Closed Access | Times Cited: 61
The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures
Ling‐Ling Chen, Teniola Oke, Nicholas Siegel, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 15, pp. 4018-4030
Open Access | Times Cited: 60
TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation
Kui Zang, Liangliang Hui, Min Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 43
A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer
Cheng Feng, Yuan Li, Yi Tai, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Applications of Extracellular Vesicles in Triple-Negative Breast Cancer
Frédéric St-Denis Bissonnette, Rachil Khoury, Karan Mediratta, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 451-451
Open Access | Times Cited: 26
Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer
Joan Choo, Ley Fang Kua, Mu Yar Soe, et al.
Gastric Cancer (2023) Vol. 26, Iss. 3, pp. 393-404
Open Access | Times Cited: 13
Development of prognostic index based on autophagy-related genes analysis in breast cancer
Qing-Guang Lin, Wei Liu, Yu-zhen Mo, et al.
Aging (2020) Vol. 12, Iss. 2, pp. 1366-1376
Open Access | Times Cited: 37
Racial differences in CD8+ T cell infiltration in breast tumors from Black and White women
Yara Abdou, Kristopher Attwood, Ting-Yuan David Cheng, et al.
Breast Cancer Research (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 33
Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer
Lanmei Gao, Wenying Jiang, Qiuyuan Yue, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109335-109335
Closed Access | Times Cited: 21
Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes
Konstantinos Ntostoglou, Sofia D. P. Theodorou, Tanja Proctor, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 3
Open Access | Times Cited: 4
Prediction of immunotherapy responsiveness in melanoma through single-cell sequencing-based characterization of the tumor immune microenvironment
Yucheng Dong, Zhizhuo Chen, Fan Yang, et al.
Translational Oncology (2024) Vol. 43, pp. 101910-101910
Open Access | Times Cited: 4
Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
Zhiyong Wan, Meng Cui, Jia Yang, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Research progress and perspectives on the application of tyramide signal amplification-based multiplex immunohistochemistry/immunofluorescence: a bibliometrics analysis
Xiaotong Yu, Chen Huang, Yan Song, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Manufacturing and Financial Evaluation of Peptide-Based Neoantigen Cancer Vaccines for Triple-Negative Breast Cancer in the United Kingdom: Opportunities and Challenges
Alena Nováková, Stephen Morris, Ludovica Vaiarelli, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 144-144
Open Access
The prognostic value of the tumor-stroma ratio compared to tumor-infiltrating lymphocytes in triple-negative breast cancer: a review
Layla Andour, Sophie C. Hagenaars, Barbara Gregus, et al.
Virchows Archiv (2025)
Open Access
EGFR mutation status affects intra-tumoural heterogeneity of PD-L1 expression but not agreement between assays in resectable non-small cell lung cancer
Stephanie P.L. Saw, Angela Takano, Siqin Zhou, et al.
Lung Cancer (2025) Vol. 202, pp. 108463-108463
Open Access
Page 1 - Next Page

Scroll to top